|
Name |
Cytochalasin R
|
Molecular Formula | C28H39NO5 | |
IUPAC Name* |
(1R,2R,3Z,5R,7S,9Z,11R,12S,13R,14S,15R,16S)-16-benzyl-2,5,12,13-tetrahydroxy-5,7,13,14-tetramethyl-17-azatricyclo[9.7.0.01,15]octadeca-3,9-dien-18-one
|
|
SMILES |
C[C@H]1C/C=C\[C@H]2[C@@H]([C@]([C@H]([C@@H]3[C@@]2([C@@H](/C=C\[C@](C1)(C)O)O)C(=O)N[C@H]3CC4=CC=CC=C4)C)(C)O)O
|
|
InChI |
InChI=1S/C28H39NO5/c1-17-9-8-12-20-24(31)27(4,34)18(2)23-21(15-19-10-6-5-7-11-19)29-25(32)28(20,23)22(30)13-14-26(3,33)16-17/h5-8,10-14,17-18,20-24,30-31,33-34H,9,15-16H2,1-4H3,(H,29,32)/b12-8-,14-13-/t17-,18-,20-,21-,22+,23-,24-,26-,27+,28+/m0/s1
|
|
InChIKey |
KPQRGEZMOJERCR-IIMDGTFYSA-N
|
|
Synonyms |
Cytochalasin R
|
|
CAS | NA | |
PubChem CID | 101588729 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 469.6 | ALogp: | 2.3 |
HBD: | 5 | HBA: | 5 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 110.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 34 | QED Weighted: | 0.428 |
Caco-2 Permeability: | -5.292 | MDCK Permeability: | 0.00002530 |
Pgp-inhibitor: | 0.005 | Pgp-substrate: | 0.981 |
Human Intestinal Absorption (HIA): | 0.142 | 20% Bioavailability (F20%): | 0.961 |
30% Bioavailability (F30%): | 0.587 |
Blood-Brain-Barrier Penetration (BBB): | 0.464 | Plasma Protein Binding (PPB): | 75.84% |
Volume Distribution (VD): | 0.738 | Fu: | 21.52% |
CYP1A2-inhibitor: | 0.024 | CYP1A2-substrate: | 0.137 |
CYP2C19-inhibitor: | 0.101 | CYP2C19-substrate: | 0.78 |
CYP2C9-inhibitor: | 0.112 | CYP2C9-substrate: | 0.572 |
CYP2D6-inhibitor: | 0.015 | CYP2D6-substrate: | 0.16 |
CYP3A4-inhibitor: | 0.778 | CYP3A4-substrate: | 0.276 |
Clearance (CL): | 4.521 | Half-life (T1/2): | 0.859 |
hERG Blockers: | 0.377 | Human Hepatotoxicity (H-HT): | 0.681 |
Drug-inuced Liver Injury (DILI): | 0.095 | AMES Toxicity: | 0.043 |
Rat Oral Acute Toxicity: | 0.649 | Maximum Recommended Daily Dose: | 0.916 |
Skin Sensitization: | 0.411 | Carcinogencity: | 0.019 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
Respiratory Toxicity: | 0.9 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005131 | 0.824 | D06CWH | 0.272 | ||||
ENC005133 | 0.813 | D03IKT | 0.244 | ||||
ENC002261 | 0.813 | D0F1EX | 0.244 | ||||
ENC003653 | 0.813 | D05VQI | 0.244 | ||||
ENC004243 | 0.769 | D0SP3D | 0.242 | ||||
ENC005132 | 0.704 | D0V3ZA | 0.241 | ||||
ENC003169 | 0.704 | D08PIQ | 0.239 | ||||
ENC004544 | 0.670 | D0R1BD | 0.238 | ||||
ENC004918 | 0.670 | D0I0DL | 0.237 | ||||
ENC002762 | 0.664 | D09NNH | 0.235 |